Results 81 to 90 of about 3,179,078 (198)

The use, appropriateness and outcomes of outpatient parenteral antimicrobial therapy [PDF]

open access: yesArchives of Disease in Childhood, 2016
ObjectiveOutpatient parenteral antimicrobial therapy (OPAT) is increasingly used to treat children at home, but studies in children are scarce. We aimed to describe the use, appropriateness and outcomes of OPAT in children.DesignThis was a 12-month prospective observational study.SettingThe hospital-in-the-home programme of The Royal Children's ...
Kate A Hodgson   +8 more
openaire   +2 more sources

Tissue and Serum Concentrations of Time‐Dependent Antibiotics in Infected Diabetic Foot Ulcers by Bolus or Continuous Administration: The Randomised DFIATIM Trial

open access: yesDiabetes/Metabolism Research and Reviews, Volume 42, Issue 5, July 2026.
ABSTRACT Aims The clinical effectiveness of antibiotic (ATB) therapy in patients with infected diabetic foot ulcers (iDFUs) depends on achieving sufficient ATB concentrations in both serum and peripheral tissues. This study evaluated the availability and bactericidal activity of the time‐dependent ATBs—ceftazidime (CTZ) and amoxicillin/clavulanate (AMC)
Radka Jarošíková   +14 more
wiley   +1 more source

Barriers and facilitators for the implementation and expansion of outpatient parenteral antimicrobial therapy: a systematic review [PDF]

open access: yes
Outpatient parenteral antimicrobial therapy (OPAT) has been expanding in recent years and serves as a viable solution in reducing the shortage of hospital beds. However, the wider implementation of OPAT faces numerous challenges.
Cotta, MO   +4 more
core   +1 more source

Incidence, Mortality, and Determinants of Ventilator‐Associated Pneumonia Among Pediatric Patients at the National Referral Hospital, Bhutan: A Prospective Cohort Study

open access: yesHealth Science Reports, Volume 9, Issue 7, July 2026.
ABSTRACT Background Ventilator‐associated pneumonia (VAP) is a common healthcare‐associated infection in pediatric intensive care units (PICUs). In Bhutan, baseline data on VAP are limited. This study aimed to determine the incidence, mortality, and factors associated with VAP among mechanically ventilated pediatric patients at the Jigme Dorji ...
Tashi Tshering   +3 more
wiley   +1 more source

Sustained Treatment Success With Ustekinumab in Symptomatic Stricturing Crohn's Disease: A Retrospective Single‐Arm Observational Cohort Study

open access: yesMedComm, Volume 7, Issue 7, July 2026.
Data on ustekinumab (UST) for symptomatic stricturing Crohn's disease remain scarce in China. This cohort study screened 73 patients from June 2022 to April 2024, of whom 54 were eligible included, with 81.5% achieving 52‐week treatment success. Most attained sustained clinical remission alongside improved inflammation and strictures. Nonsmoking status
Jingwen Liu   +5 more
wiley   +1 more source

sj-docx-2-tai-10.1177_20499361231179668 – Supplemental material for Predictors of adverse safety events and unscheduled care among an outpatient parenteral antimicrobial therapy (OPAT) patient cohort

open access: yes, 2023
Supplemental material, sj-docx-2-tai-10.1177_20499361231179668 for Predictors of adverse safety events and unscheduled care among an outpatient parenteral antimicrobial therapy (OPAT) patient cohort by Kaylyn N. Billmeyer, Jennifer K.
Alison L. Galdys (16322924)   +5 more
core   +1 more source

Development and Physicochemical Stability of an Oral GS‐441524 Suspension for Weight‐Adjusted Treatment of Feline Infectious Peritonitis

open access: yesVeterinary Medicine and Science, Volume 12, Issue 4, July 2026.
A 50 mg/mL oral GS‑441524 suspension for feline infectious peritonitis (FIP) was developed and shown to remain physico‐chemically stable for at least 12 weeks under tested storage conditions and 28 days in‑use, supporting accurate weight‑adjusted dosing as an extemporaneously compounded formulation under veterinary supervision.
Cédric Wernli, Ursula Streit
wiley   +1 more source

sj-docx-2-tai-10.1177_20499361231214901 – Supplemental material for Best practices, implementation and challenges of outpatient parenteral antimicrobial therapy: results of a worldwide survey among healthcare providers

open access: yes, 2023
Supplemental material, sj-docx-2-tai-10.1177_20499361231214901 for Best practices, implementation and challenges of outpatient parenteral antimicrobial therapy: results of a worldwide survey among healthcare providers by Moska Hassanzai, Fadime Adanç ...
Nelianne Verkaik (8482521)   +7 more
core   +1 more source

Update of the list of qualified presumption of safety (QPS) recommended microbiological agents intentionally added to food or feed as notified to EFSA 24: Suitability of taxonomic units notified to EFSA until March 2026

open access: yesEFSA Journal, Volume 24, Issue 7, July 2026.
Abstract The Qualified Presumption of Safety (QPS) process was developed to provide a harmonised safety assessment approach to support EFSA Scientific Panels and Units. The QPS approach assesses the taxonomic identity, body of knowledge and safety of microorganisms intentionally added to the food and feed chain.
EFSA Panel on Biological Hazards (BIOHAZ)   +26 more
wiley   +1 more source

sj-docx-3-tai-10.1177_20499361231214901 – Supplemental material for Best practices, implementation and challenges of outpatient parenteral antimicrobial therapy: results of a worldwide survey among healthcare providers

open access: yes, 2023
Supplemental material, sj-docx-3-tai-10.1177_20499361231214901 for Best practices, implementation and challenges of outpatient parenteral antimicrobial therapy: results of a worldwide survey among healthcare providers by Moska Hassanzai, Fadime Adanç ...
Nelianne Verkaik (8482521)   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy